Table 3.
Female sex | Age | DM duration | BMI | Systolic BP | Diastolic BP | FPG | HbA1c | OHA only | Insulin only | OHA and insulin | |
---|---|---|---|---|---|---|---|---|---|---|---|
TIR | |||||||||||
r | −0.142 | −0.145 | −0.252 | 0.008 | 0.043 | 0.132 | −0.479 | −0.574 | 0.283 | −0.090 | −0.225 |
P‐value | 0.007 | 0.006 | <0.001 | 0.913 | 0.415 | 0.012 | <0.001 | <0.001 | 0.001 | 0.087 | <0.001 |
Fasting C‐peptide | TC | TG | HDL‐C | LDL‐C | eGFR | smoking | drinking | TCSS | abnormal NCT | NRS | |
---|---|---|---|---|---|---|---|---|---|---|---|
TIR | |||||||||||
r | 0.088 | −0.067 | −0.024 | 0.010 | −0.068 | 0.095 | −0.068 | −0.159 | −0.388 | −0.245 | −0.506 |
P‐value | 0.094 | 0.205 | 0.651 | 0.937 | 0.195 | 0.078 | 0.198 | 0.002 | <0.001 | <0.001 | <0.001 |
Pearson correlation analysis was used to evaluate the relationship between time in range (TIR) level and other clinical variables. BMI, body mass index; eGFR, estimated glomerular filtration rate; FPG, fasting plasma glucose; HbA1c, glycated hemoglobin; HDL‐C, high‐density lipoprotein cholesterol; LDL‐C, low‐density lipoprotein cholesterol; NCT, nerve conduction test; NRS, numerical rating scale; OHA, oral hypoglycemic agent; TC, total cholesterol; TCSS, Toronto Clinical Scoring System; TG, triglyceride.